GSK (then SmithKline Beecham) developed a Lyme disease vaccine called Lymerix back in the 1990s, but it fell foul of anti-vaccine sentiment and the drugmaker eventually pulled it off the market in ...
GlaxoSmithKline (then SmithKline Beecham) developed a Lyme disease vaccine called Lymerix back in the 1990s, but it fell foul of anti-vaccine sentiment and the drugmaker eventually pulled it off ...
View Full Profile. Learn about our Editorial Policies. The researchers first tested how their OspA mRNA vaccine affected cells of the adaptive immune system by isolating immune cells from mice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results